Improved Postmarket Compliance Requires FDA, Industry Attention – Phillips
This article was originally published in The Gray Sheet
Executive Summary
PMA sponsors should negotiate post-approval conditions with FDA prior to accepting an approval order rather than seeking changes later, CDRH Office of Device Evaluation's Philip Phillips advises